Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Chris Yoo"'
Publikováno v:
Respirology Case Reports, Vol 11, Iss 9, Pp n/a-n/a (2023)
Abstract Alteplase as a fibrinolytic can be used to break up fibrin to encourage clot breakdown for clinical use. In the pleural space, it is used for symptomatic loculated malignant pleural effusions and pleural infections and can potentially avoid
Externí odkaz:
https://doaj.org/article/e1878ac4d2cf40be98ae04a823da2572
Autor:
Chris Yoo
Publikováno v:
Canadian Journal of Biotechnology, Vol 1, Iss Special Issue-Supplement, Pp 235-235 (2017)
Genomic data is estimated to be doubling every seven months with over 2 trillion bases from whole genome sequence studies deposited in Genbank in just the last 15 years alone. Recent advances in compute and storage have enabled the use of artificial
Externí odkaz:
https://doaj.org/article/07d5fe20b0d8441899c2969e7ac1e6fb
Autor:
Pratap Shankar, Avinash Agarwal, Nawazish Alam, Anil Kumar Tripathi, Abhishek Mishra, Shivani Dixit, Rebecca Chowdhry, Ravi Kant, Hari Shyam, Julia Varkey, Archana Mishra, Chris Yoo, Bianca Argente, Madan Lal Brahma Bhatt, Neetu Singh, Margaret Linan, Dinesh Kumar Sahu, Niranjan Parida
Publikováno v:
Oncotarget
Previously, it has been stated that the BCR-ABL fusion-protein is sufficient to induce Chronic Myeloid Leukemia (CML), but additional genomic-changes are required for disease progression. Hence, we profiled control and tyrosine kinase inhibitors (TKI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0861cbfb13cce28bee33bce3e2acc6b0
https://doi.org/10.18632/oncotarget.25752
https://doi.org/10.18632/oncotarget.25752
Autor:
Pieter Derdeyn, Kendyl Douglas, Daniel D. Von Hoff, Spyro Mousses, Jeff Kiefer, Chris Yoo, Abhishek Kothari, David Schneider
Publikováno v:
Journal of Clinical Oncology. 37:2598-2598
2598 Background: Synthetic lethal targets are proteins that are contextually vulnerable. Inhibitors of PARP1, for example, selectively produce a lethal phenotype in the context of cancer cells which have lost BRCA1 or BRCA2 function. As a high mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7683d40664f4917796b367a7dea3b2b
https://doi.org/10.1200/jco.2019.37.15_suppl.2598
https://doi.org/10.1200/jco.2019.37.15_suppl.2598
Autor:
Marcus King, Swati Gupta, Mariette McCormick, Chris Yoo, Alice Bond, Ollie Hobbs, Hilda Mulligan, Hannah Graham
Publikováno v:
New Zealand Journal of Physiotherapy. 44
Difficulty with social interactions is a feature of Autistic Spectrum Disorder (ASD) and can be present in children who have other developmental disorders. A novel application using computer technology was designed by Callaghan Innovation to improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f47400578fdf2bea7da2187085aceb0c
https://doi.org/10.15619/nzjp/44.1.06
https://doi.org/10.15619/nzjp/44.1.06
Autor:
Ravi Kant, Anil Kumar Tripathi, Avinash Agarwal, Chris Yoo, Archana Mishra, Margaret Linan, Dinesh Kumar Sahu, Julia Varkey, Rebecca Chowdhry, Madan L.B. Bhatt, Bianca Argente, Neetu Singh
Publikováno v:
Cancer Research. 78:3435-3435
Previously it has been stated that BCR-ABL1 fusion protein is sufficient to induce CML, but additional genomic changes are required for disease progression. Based on this notion, we profiled control and Tyrosine Kinase Inhibitors (TKI)-treated-CML-sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee690b09476efcec1301551081591296
https://doi.org/10.1158/1538-7445.am2018-3435
https://doi.org/10.1158/1538-7445.am2018-3435